腫瘍病理鑑別診断アトラス　子宮体癌

出版社： 文光堂
著者：
発行日： 2014-11-07
分野： 臨床医学：基礎  >  臨床病理学
ISBN： 9784830622427
シリーズ： 腫瘍病理鑑別診断アトラス
電子書籍版： 2014-11-07 （第1版第2刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

14,300 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

14,300 円(税込)

購入する

商品紹介

子宮体癌の病理学的特徴を詳述し，診断の要点やピットフォールを，実際の症例写真と合わせて確認することで，子宮体部腫瘍への理解が深まり，診断の精度向上に寄与する一冊．

目次

  • 腫瘍病理鑑別診断アトラス　子宮体癌

    ―目次―

    第１部　検鏡前の確認事項
    　I．子宮体癌組織分類の現状
    　II．病理標本の取扱い方

    第２部　組織型と診断の実際
    　?．子宮内膜病変
    　II．子宮間葉性（系）腫瘍
    　III．絨毛性疾患
    　IV．転移性腫瘍・その他の腫瘍・腫瘍類似病変

    第３部　鑑別ポイント
    　１．内膜生検・掻爬標本の観察の仕方
    　２．子宮内膜増殖症vs 非増殖症・非癌病変
    　３．子宮内膜病変における核異型の判定
    　４．Endometrioid intraepithelial neoplasia（EIN）の判定法
    　５．子宮内膜における化生の評価
    　６．子宮内膜癌における浸潤のとらえ方
    　７．?型子宮体癌と?型子宮体癌の鑑別
    　８．平滑筋腫瘍の悪性度評価
    　９．子宮体部腫瘍における免疫組織化学の有用性
    　　　─間葉性（系）腫瘍の鑑別を中心に─

    第４部　臨床との連携
    　?．子宮体部腫瘍の疫学
    　II．子宮内膜腫瘍の進行期と治療方針・予後
    　III．子宮間葉性（系）腫瘍・絨毛性疾患の治療および予後
    　IV．子宮体部腫瘍の経過観察と治療効果の判定
    　V．病理診断報告書の記載

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1部 検鏡前の確認事項

P.8 掲載の参考文献
1) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会他 (編) : 子宮体癌取扱い規約, 第3版, 金原出版, 2012, pp47-58
 
2) Tavassoli FA, Devilee P (eds) : WHO Classification of Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs, 3rd ed, IARC Press, Lyon, 2003, pp218-257
 
3) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs, 4th ed, IARC Press, Lyon, 2014, pp122-167
 
4) Baak JP, Mutter GL, Robboy S et al : The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer 103 : 2304-2312, 2005
 
5) Fadare O, Liang SX, Ulukus EC et al : Precursors of endometrial clear cell carcinoma. Am J Surg Pathol 30 : 1519-1530, 2006
PubMed
6) Abiko K, Baba T, Ogawa M, et al : Minimal deviation mucinous adenocarcinoma ('adenoma malignum') of the uterine corpus. Pathol Int 60 : 42-47, 2010
PubMed
7) Kuhn E, Ayhan A, Bahadirli-Talbott A et al : Molecular characterization of undifferentiated carcinoma associated with endometrioid carcinoma. Am J Surg Pathol 38 : 660-665, 2014
PubMed
8) Seidman JD, Chauhan S : Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas. Int J Gynecol Pathol 22 : 75-82, 2003
 
P.14 掲載の参考文献
1) Silverberg SG, Mutter GL, Kurman RJ et al : Epithelial tumors and related lesions. Chapter 4, Tumours of the uterine corpus. in Tavassoli FA, Devilee P (eds) : "WHO Classification of Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs", 3rd ed, IARC Press, Lyon, 2003, pp217-257
 
2) Seracchioli R, Rossi S, Govoni F et al : Fertility and obstetric outcome after laparoscopic myomectomy of large myomata : a randomized comparison with abdominal myomectomy. Hum Reprod 15 : 2663-2668, 2000
PubMed
3) Emanuel MH, Warsteker K : The Intra Uterine Morcellator : a new hysteroscopic operating technique to remove intrauterine polyps and myomas. J Minim Invasive Gynecol 12 : 62-66, 2005
 
4) 藤井雅彦 : 検体採取法 婦人科臓器. 坂本穆彦 (編) : 細胞診を学ぶ人のために, 第4版, 医学書院, 2005, pp51-53
 
5) Sany D, Singh K, Jha S : Correlation between preoperative endometrial sampling and final endometrial cancer histology. Eur J Gynaecol Oncol 33 : 142-144, 2012
 
6) 本山悌一 : 採取検体の取り扱い方. 石倉浩, 本山悌一, 森谷卓也他 (編) : 子宮腫瘍病理アトラス, 文光堂, 2007, pp5-8
 
7) Salim S, Won H, Nesbitt-Hawes E et al : Diagnosis and management of endometrial polyps : a critical review of the literature. J Minim Invasive Gynecol 18 : 569-581, 2011
PubMed
8) Lenci MA, do Nasciment VA, Grandini AB et al : Premalignant and malignant lesions in endometrial polyp in patients undergoing hysteroscopic polypectomy. Einstein (Sao Paulo) 12 : 16-21, 2014
 
9) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会他 (編) : 子宮体癌取扱い規約, 第3版, 金原出版, 2012, pp42-43
 
10) Lee DO, Jung MH, Kim HY : Prospective comparison of biopsy results from curettage and hysteroscopy in postmenopausal uterine bleeding. J Obstet Gynecol Res 37 : 1423-1426, 2011
 
11) 日本泌尿器科学会, 日本病理学会, 日本医学放射線学会 (編) : 泌尿器科・病理・放射線科 前立腺癌取扱い規約, 第4版, 金原出版, 2010, p70
 
12) Sanjuan A, Cobo T, Pahisa J et al : Preoperative and intraoperative assessment of myometrial invasion and histologic grade in endometrial cancer : role of magnetic resonance imaging and frozen section. Int J Gynecol Cancer 16 : 385-390, 2006
PubMed
13) Ivanov S : Methods for preoperative and intraoperative evaluation of the tumour infiltration and lymph node metastasis in endometrial cancer. Akush Ginekol (Sofiia) 49 : 21-24, 2010
PubMed
14) Sato S, Itamoch H, Shimada M et al : Preoperative and intraoperative assessment of depth of myometrial invasion in endometrial cancer. Int J Gynecol Cancer 19 : 884-887, 2009
 
15) Li B, Li XG, Mu LY et al : A pilot study of sentinel lymph nodes identification in patients with endometrial cancer. Bull Cancer 94 : 1-4, 2007
 
16) Cordero Garcia JM, Lopez de la Manzanara Cano CA, Garcia Vicente AM et al : Study of the sentinel node in endometrial cancer at early stages : preliminary results. Rev Esp Med Nucl Imagen Mol 31 : 243-248, 2012
PubMed
17) Dilek S, Dilek U, Dede M et al : The role of omentectomy and appendectomy during the surgical staging of clinical stage I endometrial cancer. Int J Gynecol Cancer 16 : 795-798, 2006
 

第2部 組織型と診断の実際

P.26 掲載の参考文献
1) Kurman RJ, Kaminski PF, Norris HJ : The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer 56 : 403-412, 1985
PubMed
2) Lacey JV, Ioffe OB, Ronnett BM et al : Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia : the 34-year experience in a large health plan. Br J Cancer 98 : 45-53, 2008
 
3) Kurman RJ, Norris HJ : Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 49 : 2547-2559, 1982
PubMed
4) Agostini A, Cravello L, Shojai R et al : Risk of finding an endometrial cancer when atypical hyperplasia was incidentally diagnosed on hysteroscopic resection products. Eur J Obstet Gynecol Reprod Biol 103 : 58-59, 2002
PubMed
5) Chen YL, Cheng WF, Lin MC et al : Concurrent endometrial carcinoma in patients with a curettage diagnosis of endometrial hyperplasia. J Formos Med Assoc 108 : 502-507, 2009
PubMed
6) Hahn HS, Chun YK, Kwon YI et al : Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia. Eur J Obstet Gynecol Reprod Biol 150 : 80-83, 2010
PubMed
7) Horn LC, Schnurrbusch U, Bilek K et al : Risk of progression in complex and atypical endometrial hyperplasia : clinicopathologic analysis in cases with and without progestogen treatment. Int J Gynecol Cancer 14 : 348-353, 2004
PubMed
8) Karamursel BS, Guven S, Tulunay G et al : Which surgical procedure for patients with atypical endometrial hyperplasia? Int J Gynecol Cancer 15 : 127-131, 2005
PubMed
9) Rakha E, Wong SC, Soomro I et al : Clinical outcome of atypical endometrial hyperplasia diagnosed on an endometrial biopsy : institutional experience and review of literature. Am J Surg Pathol 36 : 1683-1690, 2012
 
10) Ushijima K, Yahata H, Yoshikawa H et al : Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol 25 : 2798-2803, 2007
PubMed
11) Gunderson CC, Fader AN, Carson KA et al : Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma : a systematic review. Gynecol Oncol 125 : 477-482, 2012
PubMed
12) Levine RL, Cargile CB, Blazes MS et al : PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res 58 : 3254-3258, 1998
PubMed
13) Hayes MP, Wang H, Espinal-Witter R et al : PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia. Clin Cancer Res 12 : 5932-5935, 2006
PubMed
14) Sun H, Enomoto T, Shroyer KR et al : Clonal analysis and mutations in the PTEN and the K-ras genes in endometrial hyperplasia. Diagn Mol Pathol 11 : 204-211, 2002
 
15) Enomoto T, Inoue M, Perantoni AO et al : K-ras activation in premalignant and malignant epithelial lesions of the human uterus. Cancer Res 51 : 5308-5314, 1991
PubMed
16) Werner HM, Berg A, Wik E et al : ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. Mod Pathol 26 : 428-434, 2013
PubMed
17) Mao TL, Ardighieri L, Ayhan A et al : Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma. Am J Surg Pathol 37 : 1342-1348, 2013
PubMed
P.41 掲載の参考文献
1) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会他 (編) : 子宮体癌取扱い規約, 第3版, 金原出版, 2012
 
2) Zaino R, Carineli SG, Ellenson LH et al : Epithelial tumours and precursors. in Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : "WHO Classification of Tumours of Female Reproductive Organs", 4th ed, IARC Press, Lyon, 2014, pp125-135
 
3) Voss MA, Ganesan R, Ludeman L et al : Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation. Gynecol Oncol 124 : 15-20, 2012
 
4) Mutter GL, Matias-Guiu X, Lax SF : Endometrial adenocarcinoma.in Robboy SJ, Mutter GL, Prat J et al (eds) : "Robboy's Pathology of the Female Reproductive Tract", 2nd ed, Churchill Livingstone, London, 2008, pp393-426
 
5) Crum CP, Duska LR, Nucci MR : Adenocarcinoma, carcinosarcoma, and other epithelial tumors of the endometrium. in Crum CP, Nucci MR, Lee KR (eds) : "Diagnostic Gynecologic and Obstetric Pathology", 2nd ed, Saunders, Philadelphia, 2011, pp517-581
 
6) Musa F, Huang M, Adams B et al : Mucinous histology is a risk factor for nodal metastases in endometrial cancer. Gynecol Oncol 125 : 541-545, 2012
PubMed
7) Rauh-Hain JA, Vargas RJ, Clemmer J et al : Mucinous adenocarcinoma of the endometrium compared with endometrioid endometrial cancer : a SEER analysis. Am J Clin Oncol 2014 Jan 2 [Epub ahead of print]
 
8) 婦人科腫瘍委員会報告2012年度患者年報. 日産婦誌 66 : 995-1038, 2014
 
9) Lachance JA, Everett EN, Greer B et al : The effect of age on clinical?pathologic features, surgical morbidity and outcome in patients with endometrial cancer. Gynecol Oncol 101 : 470-475, 2006
PubMed
10) Swerdlow AJ, Jones ME : British Tamoxifen Second Cancer Study Group. Tamoxifen treatment for breast cancer and risk of endometrial cancer : a case-control study. J Natl Cancer Inst 97 : 375-384, 2005
 
11) Navaratnarajah R, Pillary OC, Hardiman P : Polycystic ovary syndrome and endometrial cancer. Semin Reprod Med 26 : 62-71, 2008
 
12) Lachiewicz MP, Kravochuck SE, O'Malley MM et al : Prevalence of occult gynecologic malignancy at the time of risk reducing and nonprophylactic surgery in patients with Lynch syndrome. Gynecol Oncol 132 : 434-437, 2014
PubMed
13) Bonadona V, Bonaiti B, Olschwang S et al : Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 305 : 2304-2310, 2011
PubMed
14) Pilarski R, Burt R, Kohlman W et al : Cowden syndrome and the PTEN hamartoma tumor syndrome : systematic review and revised diagnostic criteria. J Natl Cancer Inst 105 : 1607-1616, 2013
PubMed
15) Ellenson LH, Ronnet BM, Soslow RA et al : Endometrial carcinoma. in Kurman RJ, Ellenson LH, Ronnet BM (eds) : "Blaustein's Pathology of the Female Genital Tract", 6th ed, Springer, New York, 2011, pp393-452
 
16) Zaino RJ, Kurman R, Herbold D et al : The significance of squamous differentiation in endometrial carcinoma. Data from a Gynecologic Oncology Group study. Cancer 68 : 2293-2302, 1991
 
17) Gurda GT, Baras AS, Kurman RJ : Ki-67 index as an ancillary tool in the differential diagnosis of proliferative endometrial lesions with secretory change. Int J Gynecol Pathol 33 : 114-119, 2014
PubMed
18) Silva EG, Young RH : Endometrioid neoplasms with clear cells : a report of 21 cases in which the alteration is not of typical secretory type. Am J Surg Pathol 31 : 1203-1208, 2007
 
19) Zaino RJ, Kurman RJ, Brunetto VL et al : Villoglandular adenocarcinoma of the endometrium : a clinicopathologic study of 61 cases : a gynecologic oncology group study. Am J Surg Pathol 22 : 1379-1385, 1998
 
20) Eichhorn JH, Young RH, Clement PB : Sertoliform endometrial adenocarcinoma : a study of four cases. Int J Gynecol Pathol 15 : 119-126, 1996
PubMed
21) Murray SK, Clement PB, Young RH : Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features : a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms. Am J Surg Pathol 29 : 157-166, 2005
PubMed
22) Fujiwara M, Longacre TA : Low-grade mucinous adenocarcinoma of the uterine corpus : a rare and deceptively bland form of endometrial carcinoma. Am J Surg Pathol 35 : 537-544, 2011
PubMed
23) Young RH, Scully RE : Uterine carcinomas simulating microglandular hyperplasia. A report of six cases. Am J Surg Pathol 16 : 1092-1097, 1992
PubMed
24) Buell-Gutbrod R, Sung CJ, Lawrence WD et al : Endometrioid adenocarcinoma with simultaneous endocervical and intestinal-type mucinous differentiation : report of a rare phenomenon and the immunohistochemical profile. Diagn Pathol 8 : 128, 2013
PubMed
25) Abiko K, Baba T, Ogawa M et al : Minimal deviation mucinous adenocarcinoma ('adenoma malignum') of the uterine corpus. Pathol Int 60 : 42-47, 2010
PubMed
26) Chebib I, Chu P, Duggan MA et al : Primary signet-ring cell adenocarcinoma of the endometrium : case report and review of the literature. Int J Gynecol Pathol 29 : 269-272, 2010
PubMed
27) Silva EG, Deavers MT, Bodurka DC et al : Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma : a new type of dedifferentiated carcinoma? Int J Gynecol Pathol 25 : 52-58, 2006
PubMed
28) Longacre TA, Hendrickson MR : Diffusely infiltrative endometrial adenocarcinoma : an adenoma malignum pattern of myoinvasion. Am J Surg Pathol 23 : 69-78, 1999
PubMed
29) Pavlakis K, Messini I, Vrekoussis T et al : MELF invasion in endometrial cancer as a risk factor for lymph node metastasis. Histopathology 58 : 966-973, 2011
PubMed
30) Euscher E, Fox P, Bassett R et al : The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma. Am J Surg Pathol 37 : 1728-1736, 2013
PubMed
31) Castrillon DH, Lee KR, Nucci MR : Distinction between endometrial and endocervical adenocarcinoma : an immunohistochemical study. Int J Gynecol Pathol 21 : 4-10, 2002
PubMed
32) Kounelis S, Kapranos N, Kouri E et al : Immunohistochemical profile of endometrial adenocarcinoma : a study of 61 cases and review of the literature. Mod Pathol 13 : 379-388, 2000
PubMed
33) Saegusa M, Hashimura M, Yoshida T et al : beta-Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis. Br J Cancer 84 : 209-217, 2001
PubMed
34) Saegusa M, Okayasu I : Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. J Pathol 194 : 59-67, 2001
PubMed
35) Mutter GL, Lin MC, Fitzgerald JT et al : Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 92 : 924-930, 2000
PubMed
36) Modica I, Soslow RA, Black D et al : Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma. Am J Surg Pathol 31 : 744-751, 2007
PubMed
37) Ansari-Lari MA, Staebler A, Zaino RJ et al : Distinction of endocervical and endometrial adenocarcinomas : immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Am J Surg Pathol 28 : 160-167, 2004
PubMed
38) Reid-Nicholson M, Iyengar P, Hummer AJ et al : Immunophenotypic diversity of endometrial adenocarcinomas : implications for differential diagnosis. Mod Pathol 19 : 1091-1100, 2006
 
39) Ito K, Watanabe K, Nasim S et al : Prognostic significance of p53 overexpression in endometrial cancer. Cancer Res 54 : 4667-4670, 1994
PubMed
40) Houghton O, Connolly LE, McCluggage WG : Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2. Histopathology 53 : 156-165, 2008
PubMed
41) Silverberg SG : Problems in the differential diagnosis of endometrial hyperplasia and carcinoma. Mod Pathol 13 : 309-327, 2000
PubMed
42) Mutter GL : Endometrial intraepithelial neoplasia (EIN) : will it bring order to chaos? The Endometrial Collaborative Group. Gynecol Oncol 76 : 287-290, 2000
 
43) Bokhman JV : Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15 : 10-17, 1983
PubMed
44) Alvarez T, Miller E, Duska L et al : Molecular profile of grade 3 endometrioid endometrial carcinoma : is it a type I or type II endometrial carcinoma? Am J Surg Pathol 36 : 753-761, 2012
PubMed
45) Matias-Guiu X, Prat J : Molecular pathology of endometrial carcinoma. Histopathology 62 : 111-123, 2013
PubMed
46) Esteller M, Levine R, Baylin SB et al : MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene 17 : 2413-2417, 1998
PubMed
47) Bussaglia E, del Rio E, Matias-Guiu X et al : PTEN mutations in endometrial carcinomas : a molecular and clinicopathologic analysis of 38 cases. Hum Pathol 31 : 312-317, 2000
PubMed
48) Levine RL, Cargile CB, Blazes MS et al : PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res 58 : 3254-3258, 1998
PubMed
49) Mutter GL, Lin MC, Fitzgerald JT et al : Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 92 : 924-930, 2000
PubMed
50) Oda K, Stokoe D, Taketani Y et al : High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma. Cancer Res 65 : 10669-10673, 2005
PubMed
51) Hayes MP, Wang H, Espinal-Witter R et al : PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia. Clin Cancer Res 12 : 5932-5935, 2006
PubMed
52) Sasaki H, Nishii H, Takahashi H et al : Mutation of the Kiras protooncogene in human endometrial hyperplasia and carcinoma. Cancer Res 53 : 1906-1910, 1993
PubMed
53) Guan B, Mao TL, Panuganti PK et al : Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. Am J Surg Pathol 35 : 625-632, 2011
PubMed
54) Wiegand KC, Lee AF, Al-Agha OM et al : Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas. J Pathol 224 : 328-333, 2011
PubMed
55) Rahman M, Nakayama K, Rahman MT et al : Clinicopathologic analysis of loss of AT-rich interactive domain 1A expression in endometrial cancer. Hum Pathol 44 : 103-109, 2013
PubMed
56) Werner HM, Berg A, Wik E et al : ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. Mod Pathol 26 : 428-434, 2013
PubMed
57) Xiong J, He M, Jackson C et al : Endometrial carcinomas with significant mucinous differentiation associated with higher frequency of k-ras mutations : a morphologic and molecular correlation study. Int J Gynecol Cancer 23 : 1231-1236, 2013
PubMed
58) Yoo SH, Park BH, Choi J et al : Papillary mucinous metaplasia of the endometrium as a possible precursor of endometrial mucinous adenocarcinoma. Mod Pathol 25 : 1496-1507, 2012
PubMed
P.51 掲載の参考文献
1) Lauchlan SC : Tubal (serous) carcinoma of the endometrium. Arch Pathol Lab Med 105 : 615-618, 1981
PubMed
2) Hendrickson M, Ross J, Eifel P et al : Uterine papillary serous carcinoma : a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6 : 93-108, 1982
PubMed
3) Silverberg SG, Kurman RJ, Nogales F et al : Tumours of the uterine corpus : epithelial tumours and related lesions. in Tavassoli FA, Devilee P (eds) : "WHO Classification of Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs", 3rd ed, IARC Press, Lyon, 2003, pp221-232
 
4) Hamilton CA, Cheung MK, Osann K et al : Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer 94 : 642-646, 2006
PubMed
5) Moll UM, Chalas E, Auguste M et al : Uterine papillary serous carcinoma evolves via a p53-driven pathway. Hum Pathol 27 : 1295-1300, 1996
 
6) Mhawech-Fauceglia P, Herrmann FR, Rai H et al : IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma. Am J Clin Pathol 133 : 899-908, 2010
PubMed
7) Jia L, Liu Y, Yi X et al : Endometrial glandular dysplasia with frequent p53 gene mutation : a genetic evidence supporting its precancer nature for endometrial serous carcinoma. Clin Cancer Res 14 : 2263-2269, 2008
 
8) Wheeler DT, Bell KA, Kurman RJ et al : Minimal uterine serous carcinoma : diagnosis and clinicopathologic correlation. Am J Surg Pathol 24 : 797-806, 2000
PubMed
9) Ronnett BM, Kurman RJ : Precursor lesions of endometrial carcinoma. in Kurman RJ (ed) : "Blaustein's Pathology of the Female Genital Tract", 5th ed, Springer, New York, 2002, pp467-500
 
10) Hoang LN, Han G, McConechy M et al : Immunohistochemical characterization of prototypical endometrial clear cell carcinoma-diagnostic utility of HNF-1β and oestrogen receptor. Histopathology 64 : 585-596, 2014
 
11) Fadare O, Liang SX : Diagnostic utility of hepatocyte nuclear factor 1-beta immunoreactivity in endometrial carcinomas : lack of specificity for endometrial clear cell carcinoma. Appl Immunohistochem Mol Morphol 20 : 580-587, 2012
PubMed
12) Clarke BA, Gilks CB : Endometrial carcinoma : controversies in histopathological assessment of grade and tumour cell type. J Clin Pathol 63 : 410-415, 2010
PubMed
13) Gilks CB, Oliva E, Soslow RA : Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma. Am J Surg Pathol 37 : 874-881, 2013
PubMed
P.60 掲載の参考文献
1) Goodman A, Zukerberg LR, Rice LW et al : Squamous cell carcinoma of the endometrium : a report of eight cases and a review of the literature. Gynecol Oncol 61 : 54-60, 1996
 
2) Takeuchi K, Tsujino T, Yabuta M et al : A case of primary squamous cell carcinoma of the endometrium associated with extensive "ichthyosis uteri". Eur J Gynaecol Oncol 33 : 552-554, 2012
PubMed
3) Stockinger R, Sterlacci W, Neunteufel W et al : Verrucous carcinoma of the endometrium : a rare and challenging diagnosis. Int J Gynecol Pathol 33 : 298-301, 2014
PubMed
4) Kataoka A, Nishida T, Sugiyama T et al : Squamous cell carcinoma of the endometrium with human papillomavirus type 31 and without tumor suppressor gene p53 mutation. Gynecol Oncol 65 : 180-184, 1997
PubMed
5) Ryder DE : Verrucous carcinoma of the endometrium-a unique neoplasm with long survival. Obstet Gynecol 59 : 78S-80S, 1982
PubMed
6) Tavassoli FA, Devilee P (eds) : WHO Classification of Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs, 3rd ed, IARC Press, Lyon, 2003, pp226-228
 
7) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs, 4th ed, IARC Press, Lyon, 2014
 
8) Marino-Enriquez A, Gonzalez-Rocha T, Burgos E et al : Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation : a clinicopathologic study of 5 cases and review of the literature. Hum Pathol 39 : 1606-1613, 2008
PubMed
9) Meydanli MM, Erguvan R, Altinok MT et al : Rare case of neuroendocrine small cell carcinoma of the endometrium with paraneoplastic membranous glomerulonephritis. Tumori 89 : 213-217, 2003
PubMed
10) Huntsman DG, Clement PB, Gilks CB et al : Small-cell carcinoma of the endometrium. A clinicopathological study of sixteen cases. Am J Surg Pathol 18 : 364-375, 1994
PubMed
11) Bige O, Saatli B, Secil M et al : Small cell neuroendocrine carcinoma of the endometrium and laparoscopic staging : a clinicopathologic study of a case and a brief review of the literature. Int J Gynecol Cancer 18 : 838-843, 2008
 
12) Korcum AF, Aksu G, Ozdogan M et al : Stage I small cell carcinoma of the endometrium : survival and management options. Acta Obstet Gynecol Scand 87 : 122-126, 2008
 
13) Albores-Saavedra J, Martinez-Benitez B, Luevano E : Small cell carcinomas and large cell neuroendocrine carcinomas of the endometrium and cervix : polypoid tumors and those arising in polyps may have a favorable prognosis. Int J Gynecol Pathol 27 : 333-339, 2008
PubMed
14) Rouzbahman M, Clarke B : Neuroendocrine tumors of the gynecologic tract : select topics. Semin Diagn Pathol 30 : 224-233, 2013
PubMed
15) Nguyen ML, Han L, Minors AM et al : Rare large cell neuroendocrine tumor of the endometrium : A case report and review of the literature. Int J Surg Case Rep 4 : 651-655, 2013
PubMed
16) Quddus MR, Sung CJ, Zhang C et al : Minor serous and clear cell components adversely affect prognosis in "mixed type" endometrial carcinomas : a clinicopathology study of 36 stage-I cases. Reprod Sci 17 : 673-678, 2010
 
17) Altrabulsi B, Malpica A, Deavers MT et al : Undifferentiated carcinoma of the endometrium. Am J Surg Pathol 29 : 1316-1321, 2005
PubMed
18) Tafe LJ, Garg K, Chew I et al : Endometrial and ovarian carcinomas with undifferentiated components : clinically aggressive and frequently underrecognized neoplasms. Mod Pathol 23 : 781-789, 2010
PubMed
19) Gernow A, Ahrentsen OD : Adenoid cystic carcinoma of the endometrium. Histopathology 15 : 197-198, 1989
PubMed
20) Mhawech P, Dellas A, Terracciano LM : Glassy cell carcinoma of the endometrium : a case report and review of the literature. Arch Pathol Lab Med 125 : 816-819, 2001
PubMed
21) Rutledge F, Kotz HL, Chang SC : Mesonephric adenocarcinoma of the endometrium ; report of a case and a review of the literature. Obstet Gynecol 25 : 362-370, 1965
 
22) Vargas MP, Merino MJ : Lymphoepitheliomalike carcinoma : an unusual variant of endometrial cancer. A report of two cases. Int J Gynecol Pathol 17 : 272-276, 1998
PubMed
23) Jones H, Gold MA, Giannico G et al : Lymphoepitheliomalike carcinoma of the endometrium : immunophenotypic characterization of a rare tumor with microsatellite instability testing. Int J Gynecol Pathol 33 : 64-73, 2014
PubMed
24) Jones MA, Young RH, Scully RE : Endometrial adenocarcinoma with a component of giant cell carcinoma. Int J Gynecol Pathol 10 : 260-270, 1991
PubMed
25) Takeuchi K, Kitazawa S, Hamanishi S et al : A case of alpha-fetoprotein-producing adenocarcinoma of the endometrium with a hepatoid component as a potential source for alpha-fetoprotein in a postmenopausal woman. Int J Gynecol Cancer 16 : 1442-1445, 2006
 
26) Rossi R, Stacchiotti D, Bernardini MG et al : Primary yolk sac tumor of the endometrium : a case report and review of the literature. Am J Obstet Gynecol 204 : e3-e4, 2011
PubMed
27) Horn LC, Hanel C, Bartholdt E et al : Mixed serous carcinoma of the endometrium with trophoblastic differentiation : analysis of the p53 tumor suppressor gene suggests stem cell origin. Ann Diagn Pathol 12 : 1-3, 2008
PubMed
P.69 掲載の参考文献
1) Wells M, Palacios J, Oliva E et al : Mixed epithelial and mesenchymal tumors. in Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : "WHO Classification of Tumours of Female Reproductive Organs", 4th ed, IARC Press, Lyon, 2014, pp148-151
 
2) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会他 (編) : 子宮体癌取扱い規約, 第3版, 金原出版, 2012
 
3) Zaloudek CJ, Hendrickson MR, Soslow RA : Mesenchymal tumors of the uterus. in Kurman RJ, Ellenson LH, Ronnett BM (eds) : "Blaustein's Pathology of the Female Genital Tract, 6th ed", Springer, New York, 2011, pp455-527
 
4) Zaloudek CJ, Norris HJ : Adenofibroma and adenosarcoma of the uterus : a clinicopathologic study of 35 cases. Cancer 48 : 354-366, 1981
PubMed
5) Bettaieb I, Mekni A, Bellil K et al : Endometrial adenofibroma : a rare entity. Arch Gynecol Obstet 275 : 191-193, 2007
PubMed
6) McCluggage WG : Benign disease of the endometrium. in Kurman RJ, Ellenson LH, Ronnett BM (eds) : "Blaustein's Pathology of the Female Genital Tract, 6th ed", Springer, New York, 2011, pp307-358
 
7) Mazur MT : Atypical polypoid adenomyomas of the endometrium. Am J Surg Pathol 5 : 473-482, 1981.
PubMed
8) Matsumoto T, Hiura M, Baba T et al : Clinical management of atypical polypoid adenomyoma of the uterus. A clinicopathological review of 29 cases. Gynecol Oncol 129 : 54-57, 2013
PubMed
9) Ohishi Y, Kaku T, Kobayashi H et al : CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium. Hum Pathol 39 : 1446-1453, 2008
PubMed
10) Horita A, Kurata A, Maeda D et al : Immunohistochemical characteristics of atypical polypoid adenomyoma with special reference to h-caldesmon. Int J Gynecol Pathol 30 : 64-70, 2011
 
11) Heatley MK : Atypical polypoid adenomyoma : a systematic review of the English literature. Histopathology 48 : 609-610, 2006
PubMed
12) Clement PB, Scully RE : Mullerian adenosarcoma of the uterus. A clinicopathologic analysis of ten cases of a distinctive type of mullerian mixed tumor. Cancer 34 : 1138-1149, 1974
PubMed
13) Clement PB, Scully RE : Mullerian adenosarcoma of the uterus : a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 21 : 363-381, 1990
PubMed
14) Gallardo A, Prat J : Mullerian adenosarcoma : a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma. Am J Surg Pathol 33 : 278-288, 2009
PubMed
15) Kaku T, Silverberg SG, Major FJ et al : Adenosarcoma of the uterus : a gynecologic oncology group clinicopathologic study of 31 cases. Int J Gynecol Pathol 11 : 75-88, 1992
PubMed
16) Clement PB, Oliva E, Young RH : Mullerian adenosarcoma of the uterine corpus associated with tamoxifen therapy : a report of six cases and a review of tamoxifen-associated endometrial lesions. Int J Gynecol Pathol 15 : 222-229, 1996
 
17) Clement PB, Scully RE : Mullerian adenosarcomas of the uterus with sex cord-like elements. A clinicopathologic analysis of eight cases. Am J Clin Pathol 91 : 664-672, 1989
PubMed
18) Aggarwal N, Bhargava R, Elishaev E : Uterine adenosarcomas : diagnostic use of the proliferation marker Ki-67 as an adjunct to morphologic diagnosis. Int J Gynecol Pathol 31 : 447-452, 2012
PubMed
19) Arend R, Bagaria M, Lewin SN et al : Long-term outcome and natural history of uterine adenosarcomas. Gynecol Oncol 119 : 305-308, 2010
PubMed
20) Ellenson LH, Ronnet BM, Soslow RA et al : Endometrial carcinoma. in Kurman RJ, Ellenson LH, Ronnett BM (eds) : "Blaustein's Pathology of the Female Genital Tract", 6th ed, Springer, New York, 2011, pp394-452
 
21) Wada H, Enomoto T, Fujita M et al : Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors. Cancer Res 57 : 5379-5385, 1997
 
22) Seidman JD, Chauhan S : Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas. Int J Gynecol Pathol 22 : 75-82, 2003
 
23) Evans MJ, Langlois NE, Kitchener HC et al : Is there an association between long-term tamoxifen treatment and the development of carcinosarcoma (malignant mixed Mullerian tumor) of the uterus? Int J Gynecol Cancer 5 : 310-313, 1995
PubMed
24) McCluggage WG, Abdulkader M, Price JH et al : Uterine carcinosarcomas in patients receiving tamoxifen. A report of 19 cases. Int J Gynecol Cancer 10 : 280-284, 2000
 
25) Pothuri B, Ramondetta L, Eifel P et al : Radiation-associated endometrial cancers are prognostically unfavorable tumors : a clinicopathologic comparison with 527 sporadic endometrial cancers. Gynecol Oncol 103 : 948-951, 2006
PubMed
26) Silva EG, Deavers MT, Bodurka DC et al : Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma : a new type of dedifferentiated carcinoma? Int J Gynecol Pathol 25 : 52-58, 2006
PubMed
27) Ferguson SE, Tornos C, Hummer A et al : Prognostic features of surgical stage I uterine carcinosarcoma. Am J Surg Pathol 31 : 1653-1661, 2007
 
P.76 掲載の参考文献
1) Tavassoli FA, Deviles P (eds) : WHO Classification of Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs, 3rd ed, IARC Press, Lyon, 2003
 
2) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会他 (編) : 子宮体癌取扱い規約, 第3版, 金原出版, 2012
 
3) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs, 4th ed, IARC Press, Lyon, 2014
 
4) 岩渕啓一 : 子宮内膜間質由来の腫瘍. 石倉浩, 本山悌一, 森谷卓也他 (編) : 子宮腫瘍病理アトラス, 文光堂, 2007, pp258-261
 
5) Tavassoli FA, Norris HJ : Mesenchymal tumour of the uterus, VII. A clinicopathological study of 60 endometrial stromal nodules. Histopathology 5 : 1-10, 1981
PubMed
6) Geetha V, Rupashree S, Bhat SS : Endometrial stromal nodule with smooth muscle differentiation. Indian J Pathol Microbiol 51 : 76-77, 2008
PubMed
7) Chang KL, Crabtree GS, Lim-Tan SK et al : Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 14 : 415-438, 1997
 
8) Stemme S, Ghaderi M, Carison JW : Diagnosis of endometrial stromal tumors : a clinicopathologic study of 25 biopsy specimens with identification of problematic areas. Am J Clin Pathol 141 : 133-139, 2014
 
9) Jetley S, Rana S, Jairajpuri ZS : Low grade endometrial stromal sarcoma in premenopausal women. J Nat Sci Biol Med 5 : 214-271, 2014
PubMed
10) Shintaku M, Hashimoto H : Mixed endometrial stromal and smooth muscle tumor : report of case with focal anaplasia and early postoperative lung metastasis. Pathol Int 63 : 214-219, 2013
PubMed
11) Kanda M, Sonoyama A, Hirano H et al : Transition of lowgrade to high-grade endometrial stromal sarcoma : a case repot. Eur J Gynaecol Oncol 34 : 358-361, 2013
 
12) Sciallis AP, Bedroske PP, Schoolmeester JK et al : Highgrade endometrial stromal sarcomas : A clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features. Am J Surg Pathol 38 : 1161-1172, 2014
PubMed
13) Croce S, Hostein I, Ribeiro A et al : YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas : genetic and pathological correlations. Mod Pathol 26 : 1390-1400, 2013
PubMed
14) 梶原博 : 子宮頸部・体部間質性腫瘍の最近の話題. 病理と臨床 31 : 644-649, 2013
 
15) Feng W, Malpica A, Robboy SJ et al : Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family. Int J Gynecol Pathol 32 : 299-306, 2013
PubMed
16) D'Angelo E, Spagnali LG, Prat J : Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system. Hum Pathol 40 : 1571-1585, 2009
 
17) Chew I, Oliva E : Endometrial stromal sarcomas : a review of potential prognostic factors. Adv Anat Pathol 17 : 113-121, 2010
PubMed
P.100 掲載の参考文献
1) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs, 4th ed, IARC Press, Lyon, 2014
 
2) 土岐利彦, 藤井信吾 : 子宮に発生する間葉系腫瘍とその類縁疾患. 藤井信吾, 寺島芳輝 (編) : 図説産婦人科VIEW-25 臨床病理学, メジカルビュー, 1996, pp150-179
 
3) Zaloudek CJ, Hendrickson MR, Soslow RA : Mesenchymal tumors of the uterus. in Kurman R (ed) : "Blaustein's Pathology of the Female Genital Tract", 6th ed, Springer, New York, 2010, pp453-527
 
4) Ip PP, Tse KY, Tam KF : Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas : a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy. Adv Anat Pathol 17 : 91-112, 2010
 
5) Toledo G, Oliva E : Smooth muscle tumors of the uterus : a practical approach. Arch Pathol Lab Med 132 : 595-605, 2008
PubMed
6) Bell SW, Kempson RL, Hendrickson MR : Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 18 : 535-558, 1994
PubMed
7) Oliva E, Young RH, Clement PB, et al : Cellular benign mesenchymal tumors of the uterus. A comparative morphologic and immunohistochemical analysis of 33 highly cellular leiomyomas and six endometrial stromal nodules, two frequently confused tumors. Am J Surg Pathol 19 : 757-768, 1995
 
8) Ly A, Mills AM, McKenney JK et al : Atypical leiomyomas of the uterus : a clinicopathologic study of 51 cases. Am J Surg Pathol 37 : 643-649, 2013
PubMed
9) Downes KA, Hart WR : Bizarre leiomyomas of the uterus : a comprehensive pathologic study of 24 cases with long-term follow-up. Am J Surg Pathol 21 : 1261-1270, 1997
PubMed
10) 本山悌一 : 平滑筋腫瘍. 石倉浩, 本山悌一, 森谷卓也他 (編) : 子宮腫瘍病理アトラス, 文光堂, 2007, pp262-269
 
11) Ip PP, Lam KW, Cheung CL et al : Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas : a clinicopathologic study of 147 cases emphasiz ing the importance of drug-induced necrosis and early infarcts in leiomyomas. Am J Surg Pathol 31 : 1215-1224, 2007
 
12) Prayson RA, Goldblum JR, Hart WR : Epithelioid smoothmuscle tumors of the uterus : a clinicopathologic study of 18 patients. Am J Surg Pathol 21 : 383-391, 1997
PubMed
13) Simpson KW, Albores-Saavedra J : HMB-45 reactivity in conventional uterine leiomyosarcomas. Am J Surg Pathol 31 : 95-98, 2007
PubMed
14) Silva EG, Deavers MT, Bodurka DC et al : Uterine epithelioid leiomyosarcomas with clear cells : reactivity with HMB-45 and the concept of PEComa. Am J Surg Pathol 28 : 244-249, 2004
PubMed
15) Vang R, Kempson RL : Perivascular epithelioid cell tumor ('PEComa') of the uterus : a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors. Am J Surg Pathol 26 : 1-13, 2002
PubMed
16) Burch DM, Tavassoli FA : Myxoid leiomyosarcoma of the uterus. Histopathology 59 : 1144-1155, 2011
PubMed
17) Colgan TJ, Pendergast S, LeBlanc M : The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues. Hum Pathol 24 : 1073-1077, 1993
PubMed
18) Deligdisch L, Hirschmann S, Altchek A : Pathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomata. Fertil Steril 67 : 837-841, 1997
PubMed
19) Demopoulos RI, Mesia AF : Effects of leuprolide acetate on treatment of leiomyomata-clues to mechanisms of action. Adv Anat Pathol 5 : 129-136, 1998
PubMed
20) Sreenan JJ, Prayson RA, Biscotti CV, et al : Histopathologic findings in 107 uterine leiomyomas treated with leuprolide acetate compared with 126 controls. Am J Surg Pathol 20 : 427-432, 1996
PubMed
21) Dundr P, Povysil C, Tvrdik D, et al : Uterine leiomyomas with inclusion bodies : an immunohistochemical and ultrastructural analysis of 12 cases. Pathol Res Pract 203 : 145-151, 2007
PubMed
22) Parker RL, Young RH, Clement PB : Skeletal muscle-like and rhabdoid cells in uterine leiomyomas. Int J Gynecol Pathol 24 : 319-325, 2005
PubMed
23) Oliva E, Young RH, Amin MB et al : An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus : a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies. Am J Surg Pathol 26 : 403-412, 2002
PubMed
24) Leitao MM, Soslow RA, Nonaka D et al : Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 101 : 1455-1462, 2004
PubMed
25) Amada S, Nakano H, Tsuneyoshi M : Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus : a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins. Int J Gynecol Pathol 14 : 134-142, 1995
PubMed
26) Chen L, Yang B : Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors. Int J Gynecol Pathol 27 : 326-332, 2008
 
27) Jeffers MD, Farquharson MA, Richmond JA et al : P53 Immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus. J Pathol 177 : 65-70, 1995
 
28) Mittal K, Demopoulos RI : MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors. Hum Pathol 32 : 984-987, 2001
PubMed
29) O'Neill CJ, McBride HA, Connolly LE et al : Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential. Histopathology 50 : 851-858, 2007
PubMed
30) Zhai YL, Kobayashi Y, Mori A et al : Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas. Int J Gynecol Pathol 18 : 20-28, 1999
PubMed
31) Bodner-Adler B, Bodner K, Czerwenka K et al : Expression of p16 protein in patients with uterine smooth muscle tumors : an immunohistochemical analysis. Gynecol Oncol 96 : 62-66, 2005
PubMed
32) Atkins KA, Arronte N, Darus CJ et al : The use of p16 in enhancing the histologic classification of uterine smooth muscle tumors. Am J Surg Pathol 32 : 98-102, 2008
PubMed
33) Mills AM, Ly A, Balzer BL et al : Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma : immunohistochemical study of 68 cases with clinical follow-up. Am J Surg Pathol 37 : 634-642, 2013
PubMed
34) Mehine M, Kaasinen E, Makinen N et al : Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med 369 : 43-53, 2013
PubMed
35) Makinen N, Mehine M, Tolvanen J et al : MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 334 : 252-255, 2011
PubMed
36) Matsubara A, Sekine S, Yoshida M et al : Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours. Histopathology 62 : 657-661, 2013
PubMed
P.107 掲載の参考文献
1) Hendrickson MR, Tavassoli FA, Kempson RL et al : Mesenchymal tumours and related lesions. in Fattaneh A, Tavassoli FA, Devilee P (eds) : "WHO Classification of Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs", 3rd ed, IARC Press, Lyon, 2003, pp242-244
 
2) Zaloudek CJ, Hendrickson MR, Soslow RA : Mesenchymal Tumors of the Uterus. in Kurman RJ, Ellenson LH, Ronnett BM (eds) : "Blaustein's Pathology of the Female Genital Tract", 6th ed, Springer, New York, 2011, pp478-480, pp496-498, pp514-515
 
3) Oliva E, Clement PB, Young RH et al : Mixed endometrial stromal and smooth muscle tumors of the uterus : a clinicopathologic study of 15 cases. Am J Surg Pathol 22 : 997-1005, 1998
PubMed
4) Fadare O : Perivascular epithelioid cell tumor (PEComa) of the uterus : an outcome-based clinicopathologic analysis of 41 reported cases. Adv Anat Pathol 15 : 63-75, 2008
PubMed
5) Park SH, Ro JY, Kim HS et al : Perivascular epithelioid cell tumor of the uterus : immunohistochemical, ultrastructural and molecular study. Pathol Int 53 : 800-805, 2003
PubMed
6) Nakayama H, Teramoto H, Teramoto M : True incidence of uterine adenomatoid tumors. Biomed Rep 1 : 352-354, 2013
PubMed
P.124 掲載の参考文献
1) 日本産婦人科学会, 日本病理学会 (編) : 絨毛性疾患取扱い規約, 第3版, 金原出版, 2011
 
2) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs, 4th ed, IARC Press, Lyon, 2014
 
3) Kajii T, Ohama K : Androgenetic origin of hydatidiform mole. Nature 268 : 633-634, 1977
PubMed
4) Szulman AE, Philippe E, Boue JG et al : Human triploidy : association with partial hydatidiform moles and nonmolar conceptuses. Hum Pathol 11 : 1016-1021, 1981
PubMed
5) Steigrad SJ : Epidemiology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol 17 : 837-847, 2003
PubMed
6) Matsui H, Iitsuka Y, Yamazawa K et al : Changes in the incidence of molar pregnancies. A population-based study in Chiba Prefecture and Japan between 1974 and 2000. Hum Reprod 18 : 172-175, 2003
PubMed
7) Womack C, Elston CW : Hydatidiform mole in Nottingham : a 12-year retrospective epidemiological and morphological study. Placenta 6 : 93-105, 1985
 
8) Baergen RN, Kelly T, McGinniss MJ et al : Complete hydatidiform mole with a coexistent embryo. Hum Pathol 27 : 731-734, 1996
PubMed
9) Chilosi M, Piazzola E, Lestani M et al : Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest 78 : 269-276, 1998
PubMed
10) Fox H, Sebire N : Pathology of the Placenta, Sanders, Philadelphia, 2007, pp438-440
 
11) Hatanaka K, Higashi M, Fujibayashi M et al : A case of complete hydatidiform mole in a perimenopausal woman with diagnostic usefulness of p57 (kip2) immunohistochemistry and HER2 fluorescent in situ hybridization. Pathol Res Pract 208 : 118-120, 2012
 
12) Cheung AN, Sit AS, Chung LP et al : Detection of heterozygous XY complete hydatidiform mole by chromosome in situ hybridization. Gynecol Oncol 55 : 386-392, 1994
PubMed
13) Gaber LW, Redline RW, Mostoufi-Zadeh M et al : Invasive partial mole. Am J Clin Pathol 85 : 722-724, 1986
PubMed
14) Pham T, Steele J, Stayboldt C et al : Placental mesenchymal dysplasia is associated with high rates of intrauterine growth restriction and fetal demise : A report of 11 new cases and a review of the literature. Am J Clin Pathol 126 : 67-78, 2006
 
15) Altieri A, Franceschi S, Ferlay J et al : Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol 4 : 670-678, 2003
PubMed
16) Fukunaga M, Nomura K, Ushigome S : Choriocarcinoma in situ at a first trimester. Report of two cases indicating an origin of trophoblast of a stem villus. Virchows Arch 429 : 185-188, 1996
 
17) Takai N, Miyazaki T, Yoshimatsu J et al : Intraplacental choriocarcinoma with fetomaternal transfusion. Pathol Int 50 : 258-261, 2000
PubMed
18) Mao TL, Kurman RJ, Huang CC et al : Immunohistochemistry of choriocarcinoma : an aid in differential diagnosis and in elucidating pathogenesis. Am J Surg Pathol 31 : 1726-1732, 2007
PubMed
19) Kurman RJ, Scully RE, Norris HJ : Trophoblastic pseudotumor of the uterus : an exaggerated form of "syncytial endometritis" simulating a malignant tumor. Cancer 38 : 1214-1226, 1976
PubMed
20) Young RH, Scully RE : Placental-site trophoblastic tumor : current status. Clin Obstet Gynecol 27 : 248-258, 1984
PubMed
21) Baergen RN, Rutgers JL, Young RH et al : Placental site trophoblastic tumor : A study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol 100 : 511-520, 2006
PubMed
22) Shih IM, Kurman RJ : Epithelioid trophoblastic tumor : a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol 22 : 1393-1403, 1998
PubMed
23) Allison KH, Love JE, Garcia RL : Epithelioid trophoblastic tumor : review of a rare neoplasm of the chorionic-type intermediate trophoblast. Arch Pathol Lab Med 130 : 1875-1877, 2006
PubMed
P.132 掲載の参考文献
1) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs, 4th ed, IARC Press, Lyon, 2014
 
2) Kumar NB, Hart WR : Metastases to the uterine corpus from extragenital cancers. A clinicopathologic study of 63 cases. Cancer 50 : 2163-2169, 1982
 
3) Blaustein A, Kurman RJ : Blaustein's Pathology of the Female Genital Tract, Springer, New York, 2011
 
4) Soliman PT, Slomovitz BM, Broaddus RR et al : Synchronous primary cancers of the endometrium and ovary : A single institution review of 84 cases. Gynecol Oncol 94 : 456-462, 2004
PubMed
5) Fadare O, James S, Desouki MM et al : Coordinate patterns of estrogen receptor, progesterone receptor, and Wilms tumor 1 expression in the histopathologic distinction of ovarian from endometrial serous adenocarcinomas. Ann Diagn Pathol 17 : 430-433, 2013
PubMed
6) Hara F, Kiyoto S, Takabatake D et al : Endometrial metastasis from breast cancer during adjuvant endocrine therapy. Case Rep Oncol 3 : 137-141, 2010
PubMed
7) Wani Y, Notohara K, Saegusa M et al : Aberrant Cdx2 expression in endometrial lesions with squamous differentiation : important role of Cdx2 in squamous morula formation. Hum Pathol 39 : 1072-1079, 2008
PubMed
8) Siami K, McCluggage WG, Ordonez NG et al : Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas. Am J Surg Pathol 31 : 1759-1763, 2007
PubMed
9) Kumar S, Shah JP, Bryant CS et al : Radiation-associated endometrial cancer. Obstet Gynecol 113 : 319-325, 2009
PubMed
10) Lu K, Dinh M, Kohlmann W et al : Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol 105 : 3 : 569-574, 2005
PubMed
11) Fox H, More JR : Primary malignant lymphoma of the uterus. J Clin Pathol 18 : 723-728, 1965
PubMed
12) Aozasa K, Saeki K, Ohsawa M et al : Malignant lymphoma of the uterus. Report of seven cases with immunohistochemical study. Cancer 72 : 1959-1964, 1993
PubMed
13) Geyer JT, Ferry JA, Harris NL et al : Florid reactive lymphoid hyperplasia of the lower female genital tract (lymphoma-like lesion) : A benign condition that frequently harbors clonal immunoglobulin heavy chain gene rearrangements. Am J Surg Pathol 34 : 161-168, 2010
PubMed
14) Chuang SS, Lin CN, Li CY et al : Uterine leiomyoma with massive lymphocytic infiltration simulating malignant lymphoma. A case report with immunohistochemical study showing that the infiltrating lymphocytes are cytotoxic T cells. Pathol Res Pract 197 : 135-138, 2001
PubMed
15) Czernobilsky B : Uterine tumors resembling ovarian sex cord tumors : an update. Int J Gynecol Pathol 27 : 229-235, 2008
PubMed
16) Umeda S, Tateno M, Miyagi E et al : Uterine tumors resembling ovarian sex cord tumors (UTROSCT) with metastasis : clinicopathological study of two cases. Int J Clin Exp Pathol 7 : 1051-1059, 2014
PubMed
17) Tavassoli F : Melanotic paraganglioma of the uterus. Cancer 58 : 942-948, 1986
PubMed
18) Dal Cin P, De Wolf F, Klerckx P et al : The 6p21 chromosome region is nonrandomly involved in endometrial polyps. Gynecol Oncol 46 : 393-396, 1992
PubMed
19) Rabban JT, Zaloudek CJ, Shekitka KM et al : Inflammatory myofibroblastic tumor of the uterus : A clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors. Am J Surg Pathol 29 : 1348-1355, 2005
PubMed

第3部 鑑別ポイント

P.139 掲載の参考文献
1) Phillips V, McCluggage WG : Results of a questionnaire regarding criteria for adequacy of endometrial biopsies. J Clin Pathol 58 : 417-419, 2005
PubMed
2) Bakour SH, Khan KS, Gupta JK : Controlled analysis of factors associated with insufficient sample on outpatient endometrial biopsy. Br J Obstet Gynecol 107 : 1312-1314, 2000
 
3) McCluggage WG : My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol 59 : 801-812, 2008
 
4) Silverberg SG : The endometrium. Pathologic principle and pitfalls. Arch Pathol Lab Med 131 : 372-382, 2007
 
5) Ewies AAA, Shaaban KAA, Merard R et al : Endometrial biopsy in women with abnormal uterine bleeding. Inadequate and unassessable categorization is not clinically relevant. J Clin Pathol 67 : 673-677, 2014
 
6) Hill CB, Prihoda TJ, Sharkey FE : Number of levels needed for diagnosis of endometrial biopsies. Histopathology 47 : 225-226, 2005
PubMed
7) Reichert RA : Diagnostic Gynecologic and Obstetric Pathology : An Atlas and Text, Lippincott Williams & Wilkins, Philadelphia, 2012, pp205-209
 
8) Demirkiran F, Yavuz E, Erenel HG et al : Which is the best technique for endometrial sampling? Aspiration (pipelle) versus dilatation and curettage (D&C). Arch Gynecol Obstet 286 : 1277-1282, 2012
 
9) Lee DO, Jung MH, Kim HY : Prospective comparison of biopsy results from curettage and hysteroscopy in postmenopausal uterine bleeding. J Obstet Gynecol Res 37 : 1423-1426, 2011
 
10) Stock RJ, Kanbour A : Prehysterectomy curettage. Obstet Gynecol 45 : 537-541, 1975
PubMed
11) Dijkhuizen FP, Mol BW, Brolmann HA et al : The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia : a meta-analysis. Cancer 89 : 1765-1772, 2000
PubMed
P.145 掲載の参考文献
1) Huang E, Hornstein MD, Stewart EA et al : Evaluation of the cyclic endometrium and benign endometrial disorders. in Crum CP, Nucci MR, Lee KR (eds) : "Diagnostic Gynecologic and Obstetric Pathology", 2nd ed, Elsevier Saunders, Philadelphia, 2011, pp410-412
 
2) Silverberg SG : Problems in the differential diagnosis of endometrial hyperplasia and carcinoma. Mod Pathol 13 : 309-327, 2000
PubMed
3) Kim KR, Peng R, Ro JY et al : A diagnostically useful histopathologic feature of endometrial polyp. The long axis of endometrial glands arranged parallel to surface epithelium. Am J Surg Pathol 28 : 1057-1062, 2004
 
4) Malpica A, Deavers MT, Euscher E : Biopsy Interpretation of the Uterine Cervix and Corpus, Lippincott Williams & Wilkins, Philadelphia, 2010, pp134-139
 
5) Moritani S, Ichihara S, Hasegawa M et al : Stromal p16 expression differentiates endometrial polyp from endometrial hyperplasia. Virchows Arch 461 : 141-148, 2012
PubMed
6) McCluggage WG : Benign diseases of the endometrium. in Kurmann RJ, Ellenson LH, Ronnett BM (eds) : "Blaustein's Pathology of the Female Genital Tract", 6th ed, Springer, New York, 2011, pp331-332
 
7) Mutter GL, Zaino RJ, Baak JP et al : Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int J Gynecol Pathol 26 : 103-114, 2007
PubMed
P.151 掲載の参考文献
1) Kurman RJ, Kaminski PF, Norris HJ : The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer 56 : 403-412, 1985
PubMed
2) Tavassoli FA, Devilee P (eds) : WHO Classification of Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs, 3rd ed, IARC Press, Lyon, 2003
 
3) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会他 (編) : 子宮体癌取扱い規約, 第3版, 金原出版, 2012
 
4) 森谷卓也, 石倉浩, 名方保夫 : 子宮内膜増殖症の病理診断. 診断の精度と問題点. 日婦腫瘍会誌 17 : 127-131, 1999
 
5) Kendall BS, Ronnett BM, Isacson C et al : Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol 22 : 1012-1019, 1998
PubMed
6) Announcements. FIGO Stages-1988 Revision. Gynecol Oncol 35 : 125-127, 1989
 
7) Zaino RJ, Kurman RJ, Diana KL et al : The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system : a Gynecologic Oncology Group study. Cancer 75 : 81-86, 1995
 
8) Kounelis S, Kapranos N, Kouri E et al : Immunohistochemical profile of endometrial adenocarcinoma : a review of 61 cases and review of the literature. Mod Pathol 13 : 379-388, 2000
PubMed
9) D'Angelo E, Prat J : Pathology of mixed Mullerian tumours. Best Pract Res Clin Obstet Gynaecol 25 : 705-718, 2011
PubMed
P.157 掲載の参考文献
1) Sherman ME : Theories of endometrial carcinogenesis. A multidisciplinary approach. Mod Pathol 13 : 295-308, 2000
PubMed
2) 清川貴子 : 子宮体部の上皮内病変と初期病変の概念と診断基準. 病理と臨床31 : 637-643, 2013
 
3) 三上芳喜 : 子宮内膜増殖症の病理診断におけるパラダイムシフト. 日本婦人科病理学 2 : 6-10, 2011
 
4) 森谷卓也, 石倉浩, 名方保夫 : 子宮内膜増殖症の病理組織診断. 診断の精度と問題点. 日本婦人科腫瘍学会雑誌 17 : 127-131, 1999
 
5) Mutter GL, The Endometrial Cancer Group : Endometrial intraepithelial neoplasia (EIN). Will it bring order to chaos? Gynecol Oncol 76 : 287-290, 2000
PubMed
6) Zaino R, Carinelli SG, Ellenson LH et al : Epithelial tumours and precursors. in Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : "WHO Classification of Tumours of Female Reproductive Organs", 4th ed, IARC Press, Lyon, 2014, pp125-135
 
7) Mutter GL : Endometrial hyperplasia without atypia and EIN. in Mutter GL, Prat J (eds) : "Pathology of the Female Reproductive Tract", 3rd ed, Churchill Livingstone, 2009, pp349-369
 
8) Kane SE, Hecht JL : Endometrial intraepithelial neoplasia terminology in practice : 4-year experience at a single institution. Int J Gynecol Pathol 31 : 160-165, 2005
 
9) Huang EC, Mutter GL, Crum CP et al : Clinical outcome in diagnostically ambiguous foci of "gland crowding" in the endometrium. Mod Pathol 23 : 1486-1491, 2010
PubMed
10) Kapucuoglu N, Aktepe F, Kaya H et al : Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index. Pathol Res Pract 203 : 153-162, 2007
PubMed
11) Usubutun A, Mutter GL, Saglam A, et al : Reproducibility of endometrial intraepithelial neoplasia diagnosis is good, but influenced by the diagnostic style of pathologists. Mod Pathol 25 : 877-884, 2012
PubMed
12) Baak JP, Mutter GL, Robboy S et al : The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer 103 : 2304-2312, 2005
 
13) Semare LG, Ko E, Johnson NR et al : Endometrial intraepithelial neoplasia. Clinical correlates and outcomes. Obstet Gynecol 118 : 21-28, 2011
 
P.163 掲載の参考文献
1) Hendrickson MR, Kempson RL : Endometrial epithelial metaplasias : proliferations frequently misdiagnosised as adenocarcinoma. Report of 89 cases and proposed classification. Am J Surg Pathl 4 : 525-542, 1980
 
2) Zaino R, Carinelli SG, Ellenson LH et al : Epithelial tumours and precursors. in Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : "WHO Classification of Tumours of Female Reproductive Organs", 4th ed, IARC Press, Lyon, 2014, pp125-135
 
3) Silverberg SG, Kurman RJ : Tumor-like lesions. in "Atlas of the Tumor Pathology. Tumor of the Uterine Corpus and Gestational Trophoblastic Disease", AFIP, Washington DC, 1992, pp191-206
 
4) Ellenson LH, Ronetto BM, Kurman RJ : Precursor lesion of endometrial carcinoma. in : Kurman RJ (ed) : "Blaustein's Pathology of the Femail Genital Tract", 6th ed, Springer, New York, 2011, pp360-389
 
5) Litta P, Codroma A, D'Agostino G et al : Morular endometrial metaplasia : review of the literature and proposal of the management. Eur J Gynaecol Oncol 34 : 243-247, 2013
PubMed
6) Simon RA, Peng SL, Liu F et al : Tubal metaplasia of the endometrium with cytologic atypia : analysis of p53, Ki-67, TERT, and long-term follow-up. Mod Pathol 24 : 1254-1261, 2011
PubMed
7) Fujiwara M, Longacre TA : Low-grade mucinous adenocarcinoma of the uterine corpus. A rare and deceptively bland form of endometrial carcinoma. Am J Surg Pathol 35 : 537-544, 2011
PubMed
8) Yoo SH, Park BH, Choi J et al : Papillary mucinous metaplasia of the endometrium as a possible precursor of endometrial mucinous adenocarcinoma. Mod Pathol 25 : 1496-1507, 2012
PubMed
9) Moritani S, Kushima M, Ichihara S et al : Eosinophilic cell change of the endometrium : a possible relationship to mucinous differentiation. Mod Pathol 18 : 1243-1248, 2005
 
10) Zaman SS, Mazur MT : Endometrial papillary syncytial change. A nonspecific alteration associated with active breakdown. Am J Clin Pathol 99 : 741-745, 1999
 
11) McCluggage WG, McBride HA : Papillary syncytial metaplasia associated with endometrial breakdown exhibits an immunophenotype that overlaps with uterine serous carcinoma. Int J Gynecol Pathol 31 : 206-210, 2012
PubMed
P.168 掲載の参考文献
1) Tavassoli F, Kraus FT : Endometrial lesions in uteri resected for atypical endometrial hyperplasia. Am J Clin Pathol 70 : 770-779, 1978
PubMed
2) Welch WR, Scully RE : Precancerous lesions of the endometrium. Hum Pathol 8 : 503-512, 1977
PubMed
3) Kurman RJ, Norris HJ : Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 49 : 2547-2557, 1982
PubMed
4) Kendall BS, Ronnett BM, Isacson C et al : Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol 22 : 1012-1019, 1998
PubMed
5) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会他 (編) : 子宮体癌取扱い規約, 第3版, 金原出版, 2012
 
6) Zaino R, Carinelli SG, Ellenson LH et al : Epithelial tumours and precursors. in Kurman RJ, Carcangiu ML, Herrington CS, et al (eds) : "WHO Classification of Tumours of Female Reproductive Organs", 4th ed, IARC Press, Lyon, 2014, pp125-135
 
7) Phillips V, Graham CT, Manek S et al : The effects of the levonorgestrel (Mirena coil) on endometrial morphology. J Clin Pathol 56 : 305-307, 2003
PubMed
8) Silver SA, Sherman ME : Morphologic and immunophenotypic characterization of foam cells in endometrial lesions. Int J Gynecol Pathol 17 : 140-145, 1998
PubMed
9) Mazur MT, Kurman RJ : Diagnosis of Endometrial Biopsies and Curettings, 2nd ed, Springer, New York, 2005
 
10) Seemayer TA, Schurch W, Lagace R et al : Myofibroblasts in the stroma of invasive and metastatic carcinoma. A possible host response to neoplasia. Am J Surg Pathol 3 : 525-533, 1979
PubMed
11) Norris HJ, Tavassoli FA, Kurman RJ : Endometrial hyperplasia and carcinoma. Am J Surg Pathol 7 : 839-847, 1983
PubMed
12) Soslow RA, Chung MH, Rouse RV et al : Atypical polypoid adenomyofibroma (APA) versus well-differentiated endometrial carcinoma with prominent stromal matrix : an immunohistochemical study. Int J Gynecol Pathol 15 : 209-216, 1996
PubMed
13) Horita A, Kurata A, Maeda D et al : Immunohistochemical characteristics of atypical polypoid adenomyoma with special reference to h-caldesmon. Int J Gynecol Pathol 30 : 64-70, 2011
 
14) Crum CP, Duska LR, Nucci MR : Adenocarcinoma, carcinosarcoma, and other epithelial tumors of the endometrium. in Crum CP, Nucci MR, Lee KR (eds) : "Diagnostic Gynecologic and Obstetric Pathology", Elsevier Saunders, Philadelphia, 2006, pp517-581
 
15) Ali A, Black D, Soslow RA : Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma. Int J Gynecol Pathol 26 : 115-123, 2007
PubMed
16) Srodon M, Klein WM, Kurmal RJ : CD10 immunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis. Am J Surg Pathol 27 : 786-789, 2003
 
17) Nasciment AF, Hirsch MS, Cvico A et al : The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis. Mod Pathol 16 : 22-27, 2003
 
18) Jacques SM, Lawrence WD : Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis : a clinicopathologic study of 23 cases. Gynecol Oncol 37 : 401-407, 1990
PubMed
19) Mittal KR, Barwick KR : Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis. Gynecol Oncol 49 : 197-201, 1993
 
20) Ismii N, Rasty G, Ghorab Z et al : Adenomyosis involved by endometrial adenocarcinoma is a significant factor for deep myometrial invasion. Ann Diagn Pathol 11 : 252-257, 2007
 
21) Longacre TA, Hendrickson MR : Diffusely infiltrative endometrial adenocarcinoma : an adenoma malignum pattern of myoinvasion. Am J Surg Pathol 23 : 69-78, 1999
PubMed
22) Murray SK, Young RH, Scully RJ : Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma : a study of their frequency, associated diagnostic problems, and prognostic significance. Int J Gynecol Pathol 22 : 324-333, 2003
 
23) Pavlakis K, Messini I, Vrekoussis T et al : MELF invasion in endometrial cancer as a risk factor for lymph node metastasis. Histopathology 58 : 966-973, 2011
PubMed
P.174 掲載の参考文献
1) Sherman ME : Theories of endometrial carcinogenesis : a multidisciplinary approach. Mod Pathol 13 : 295-308, 2000
PubMed
2) Zaino R, Matias-Guiu X, Carinelli SG et al : Epithelial tumours and precursors. in Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : "WHO Classification of Tumours of Female Reproductive Organs", 4th ed, IARC Press, Lyon, 2014, pp125-135
 
3) 稲葉憲之 : 婦人科腫瘍委員会報告. 日産婦誌 57 : 1711-1767, 2005
 
4) Vogelstein B, Fearon ER, Hamilton SR et al : Genetic alterations during colorectal tumor development. N Engl J Med 319 : 525-532, 1988
PubMed
5) Tashiro H, Biazes MS, Wu R et al : Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57 : 3935-3940, 1997
 
6) Lax SF, Kendall B, Tashiro et al : The frequency of p53, Kras mutations, and microsatellite instability differs in endometrioid and serous carcinoma. Cancer 88 : 814-824, 2000
PubMed
7) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会他 (編) : 子宮体癌取扱い規約, 第3版, 金原出版, 2012, pp41-58
 
8) 森脇昭介, 万代光一 : 子宮体部漿液性腺癌の組織像と悪性度. 森脇昭介, 杉森 甫 (編) : 取扱い規約に沿った腫瘍鑑別診断アトラス 子宮体部, 第2版, 文光堂, 1999, pp87-97
 
9) Hamilton CA, Cheung MK, Osann K et al : Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrial corpus cancers. Br J Cancer 94 : 642-646, 2006
PubMed
10) Reid-Nicholson M, Iyengar P, Hummer AJ et al : Immunophenotypic diversity of endometrial adenocarcinomas : implications for differential diagnosis. Mod Pathol 19 : 1091-1100, 2006
 
11) Ross JC, Eifel PJ, Cox RS et al : Primary mucinous adenocarcinoma of the endometrium. A clinicopathologic and histochemical study. Am J Surg Pathol 7 : 715-729, 1983
PubMed
12) Giordano G, D'Adda T, Gnetti L et al : Endometrial mucinous microglandular adenocarcinoma : morphologic, immunohistochemical features, and emphasis in human papillomavirus status. Int J Gynecol Pathol 25 : 77-82, 2006
 
13) Carcangiu ML, Tan LK, Chambers JT : Stage Ia uterine serous carcinoma : A study of 13 cases. Am J Surg Pathol 21 : 1507-1514, 1997
PubMed
14) Mutter GL : Histopathology of genetically defined endometrial precancers. Int J Gynecol Pathol 19 : 301-309, 2000
 
15) 名方保夫, 林純一 : 漿液性腺癌. 石倉浩, 本山悌一, 森谷卓也他 (編) : 子宮腫瘍病理アトラス, 文光堂, 2007, pp210-211
 
16) Sigurd FD, Ellen SP, Brigitte MR et al : Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Hum Pathol 29 : 551-558, 1998
 
17) Sherman ME, Bitterman P, Rosenshein NB et al : Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 16 : 600-610, 1992
PubMed
P.181 掲載の参考文献
1) Bell SW, Kempson RL, Hendrickson MR : Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 18 : 535-558, 1994
PubMed
2) Jones MW, Norris HJ : Clinicopathologic study of 28 uterine leiomyosarcomas with metastasis. Int J Gynecol Pathol 14 : 243-249, 1995
PubMed
3) Lim D, Alvarez T, Nucci MR et al : Interobserver variability in the interpretation of tumor cell necrosis in uterine leiomyosarcoma. Am J Surg Pathol 37 : 650-658, 2013
PubMed
4) Mahler HR, Lindberg MR, Quick CM : Predetermined search methods can increase the yield in counting mitotic figures in uterine leiomyosarcoma (ULMS). Mod Pathol 25 : 285A, 2012
 
5) Mittal KR, Chen F, Wei JJ et al : Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas. Mod Pathol 22 : 1303-1311, 2009
 
6) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs, 4th ed, IARC Press, Lyon, 2014
 
7) Ip PP, Cheung AN, Clement PB : Uterine smooth muscle tumors of uncertain malignant potential (STUMP) : a clinicopathologic analysis of 16 cases. Am J Surg Pathol 33 : 992-1005, 2009
 
8) Ip PP, Cheung AN : Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential. Best Pract Res Clin Obstet Gynaecol 25 : 691-704, 2011
PubMed
9) Atkins KA, Arronte N, Darus CJ et al : The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors. Am J Surg Pathol 32 : 98-102, 2008
PubMed
10) Mills AM, Ly A, Balzer BL et al : Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma : immunohistochemical study of 68 cases with clinical follow-up. Am J Surg Pathol 37 : 634-642, 2013
PubMed
P.186 掲載の参考文献
1) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会他 (編) : 子宮体癌取扱い規約, 第3版, 金原出版, 2012
 
2) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs, 4th ed, IARC Press, Lyon, 2014
 
3) Imai K, Maeda M, Fujiwara H et al : Human endometrial stromal cells and decidual cells express cluster of differentiation (CD) 13 antigen/aminopeptidase N and CD10 antigen/neutral endopeptidase. Biol Reprod 46 : 328-334, 1992
PubMed
4) Chiang S, Oliva E : Cytogenetic and molecular aberrations in endometrial stromal tumors. Hum Pathol 42 : 609-617, 2011
PubMed
5) Kir G, Cetiner H, Karateke A et al : Utility of MIB-1 and estrogen and progesterone receptor in distinguishing between endometrial stromal sarcomas and endometrial stromal nodules, highly cellular leiomyomas. Int J Gynecol Cancer 15 : 337-342, 2005
PubMed
6) Lee CH, Ou WB, Marino-Enriquez A et al : 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma. Proc Natl Acad Sci USA 109 : 929-934, 2012
PubMed
7) Chiang S, Ali R, Melnyk N et al : Frequency of known gene rearrangements in endometrial stromal tumors. Am J Surg Pathol 35 : 1364-1372, 2011
PubMed
8) Lee CH, Ali RH, Rouzbahman M et al : Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement. Am J Surg Pathol 36 : 1562-1570, 2012
PubMed
9) Matias-Guiu X, Prat J : Molecular pathology of endometrial carcinoma. Histopathology 62 : 111-123, 2013
PubMed
10) Kandoth C, Schultz N, Cherniack AD et al : Integrated genomic characterization of endometrial carcinoma. Nature 497 : 67-73, 2013
PubMed
11) Akiyama-Abe A, Minaguchi T, Nakamura Y et al : Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas. Br J Cancer 109 : 1703-1710, 2013
PubMed
12) Wiegand KC, Lee AF, Al-Agha OM et al : Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas. J Pathol 224 : 328-333, 2011
PubMed
13) Fadare O, Desouki MM, Gwin K et al : Frequent expression of napsin A in clear cell carcinoma of the endometrium : potential diagnostic utility. Am J Surg Pathol 38 : 189-196, 2014
PubMed
14) Samama M, van Poelgeest M : Primary malignant lymphoma of the uterus : a case report and review of the literature. Case Rep Oncol 4 : 560-563, 2011
PubMed
15) Kim SJ : Placental site trophoblastic tumour. Best Pract Res Clin Obstet Gynaecol 17 : 969-984, 2003
PubMed

第4部 臨床との連携

P.195 掲載の参考文献
1) 青木大輔 : 婦人科腫瘍委員会報告. 2012年度患者年報. 日産婦誌 66 : 995-1022, 2014
 
2) Ellenson LH, Ronnett BM, Soslow RA et al : Endometrial Carcinoma. in Kurman RJ, Ellenson LH, Ronnett BM (eds) : "Blaustein's Pathology of the Female Genital Tract", 6th ed, Springer, New York, 2011, pp394-399
 
3) Greenlee RT, Murray T, Bolden S et al : Cancer statistics, 2000. CA Cancer J Clin 50 : 7-33, 2000
PubMed
4) Parazzini F, La Vecchia C, Bocciolone L et al : The epidemiology of endometrial cancer. Gynecol Oncol 41 : 1-16, 1991
PubMed
5) Maxwell GL, Tian C, Risinger J et al : Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma : A Gynecologic Oncology Group study. Cancer 107 : 2197-2205, 2006
 
6) Bakkum-Gamez JN, Gonzales-Bosquet J, Laack NN et al : Current issues in the management of endometrial cancer. Mayo Clin Proc 83 : 97-112, 2008
 
7) Soliman PT, Oh JC, Schmeler KM et al : Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol 105 : 575-580, 2005
PubMed
8) Yap OW, Matthews RP : Racial and ethnic disparities in cancers of the uterine corpus. J Natl Med Assoc 98 : 1930-1935, 2006
 
9) Long B, Liu FW, Bristow RE : Disparities in uterine cancer epidemiology, treatment, and sur vival among African Americans in the United States. Gynecol Oncol 130 : 652-659, 2013
 
10) Mahdi H, Schlick CJ, Kowk LL et al : Endometrial cancer in Asian and American Indian/Alaskan Native women : tumor characteristics, treatment and outcome compared to non-Hispanic white women. Gynecol Oncol 132 : 443-449, 2014
PubMed
11) Amant F, Moerman P, Neven P et al : Endometrial cancer. Lancet 366 : 491-505, 2005
PubMed
12) Munstedt K, Grant P, Woenckhaus J et al : Cancer of the endometrium : current aspects of diagnostic and treatment. World J Surg Oncol 2 : 24, 2004
PubMed
13) Lachance JA, Everett EN, Greer B et al : The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol 101 : 470-475, 2006
PubMed
14) Chang SC, Lacey JV Jr, Brinton LA et al : Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev 16 : 723-730, 2007
PubMed
15) Pavelka JC, Ben-Shachar I, Fowler JM et al : Morbid obesity and endometrial cancer : surgical, clinical, and pathologic outcomes in surgically managed patients. Gynecol Oncol 95 : 588-592, 2004
PubMed
16) Setiawan VW, Yang HP, Pike MC et al : Type I and II endometrial cancers : have they different risk factors? J Clin Oncol 31 : 2607-2618, 2013
PubMed
17) Hinshaw HD, Smith A, Rungruang B et al : The risk of subsequent malignancies in women with uterine papillary serous or clear cell endometrial cancers. Int J Gynecol Cancer 23 : 1044-1049, 2013
PubMed
18) Sutton G, Kavanagh JJ, Wolfson A et al : Corpus : mesenchymal tumors. in Hoskins WJ, Perez CA, Young RC et al (eds) : "Principles and Practice of Gynecologic Oncology", 4th ed, Lippincott Williams & Wilkins, Philadelphia, 2005, pp873-894
 
19) DiSaia DJ, Creasman WJ (eds) : Sarcoma of the uterus. in "Clinical Gynecologic Oncology", 7th ed, Mosby, Saint Louis, 2007, pp185-199
 
20) Felix AS, Cook LS, Gaudet MM et al : The epidemiology of uterine sarcomas : a pooled analysis of the epidemiology of endometrial cancer consortium. Br J Cancer 108 : 727-734, 2013
PubMed
21) 井箟一彦, 谷崎優子, 小林彩他 : 絨毛性疾患の発生動向. 婦人科がん-最新の研究動向-, 日本臨床 70 (増刊) : 699-703, 2012
 
22) Lurain JR : Gestational trophoblastic disease I : epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol 203 : 531-539, 2010
PubMed
P.202 掲載の参考文献
1) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会他 (編) : 子宮体癌取扱い規約, 第3版, 金原出版, 2012
 
2) Kokawa K, Nishiyama K, Ikeuchi M et al : Clinical outcomes of uterine sarcomas : results from 14 years worth of experience in the Kinki district in Japan (1990-2003). Int J Gynecol Cancer 16 : 1358-1363, 2006
PubMed
3) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会 (編) : 子宮体癌取扱い規約, 第2版, 金原出版, 1996
 
4) Pecorelli S : Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105 : 103-104, 2009, Erratum in : Int J Gynaecol Obstet 108 : 176, 2010
 
5) Gu M, Shi W, Barakat RR et al : Peritoneal washings in endometrial carcinoma. A study of 298 patients with histopathologic correlation. Acta Cytol 44 : 783-789, 2000
PubMed
6) Fujiwara H, Saga Y, Takahashi K et al : Omental metastases in clinical stage I endometrioid adenocarcinoma. Int J Gynecol Cancer 18 : 165-167, 2008
 
7) Tashiro H, Isacson C, Levine R et al : p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol 150 : 177-185, 1997
PubMed
8) Tashiro H, Blazes MS, Wu R et al : Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57 : 3935-3940, 1997
PubMed
9) Soslow RA, Bissonnette JP, Wilton A et al : Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes : similar outcomes belie distinctive biologic differences. Am J Surg Pathol 31 : 979-987, 2007
PubMed
10) 片渕秀隆, 田代浩徳 : 子宮内膜組織診. 日産婦誌 59 : N69-N70, 2007
 
11) Motohara K, Tashiro H, Ohtake H et al : Endometrioid adenocarcinoma arising in adenomyosis : elucidation by periodic magnetic resonance imaging evaluations. Int J Clin Oncol 13 : 266-270, 2008
PubMed
12) Westin SN, Lacour RA, Urbauer DL et al : Carcinoma of the lower uterine segment : a newly described association with Lynch syndrome. J Clin Oncol 26 : 5965-5971, 2008
PubMed
13) Phelan C, Montag AG, Rotmensch J et al : Outcome and management of pathological stage I endometrial carcinoma patients with involvement of the lower uterine segment. Gynecol Oncol 83 : 513-517, 2001
 
14) 日本婦人科腫瘍学会 (編) : 子宮体がん治療ガイドライン 2013年版, 金原出版, 2013
 
15) Chi DS, Barakat RR, Palayekar MJ et al : The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer 18 : 269-273, 2008
PubMed
16) Mariani A, Dowdy SC, Cliby WA et al : Prospective assessment of lymphatic dissemination in endometrial cancer : a paradigm shift in surgical staging. Gynecol Oncol 109 : 11-18, 2008
PubMed
17) Todo Y, Kato H, Kaneuchi M et al : Survival effect of paraaortic lymphadenectomy in endometrial cancer (SEPAL study) : a retrospective cohort analysis. Lancet 375 : 1165-1172, 2010
PubMed
18) Kim DY, Kim MK, Kim JH et al : Laparoscopic-assisted vaginal hysterectomy versus abdominal hysterectomy in patients with stage I and II endometrial cancer. Int J Gynecol Cancer 15 : 932-937, 2005
 
19) ElSahwi KS, Hooper C, De Leon MC et al : Comparison between 155 cases of robotic vs. 150 cases of open surgical staging for endometrial cancer. Gynecol Oncol 124 : 260-264, 2012
PubMed
20) Randall ME, Filiaci VL, Muss H et al : Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma : a Gynecologic Oncology Group Study. J Clin Oncol 24 : 36-44, 2006
 
21) Odunsi K, Moneke V, Tammela J et al : Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas : results of long-term follow-up. Int J Gynecol Cancer 14 : 659-664, 2004
PubMed
22) Ushijima K, Yahata H, Yoshikawa H et al : Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol 25 : 2798-2803, 2007
PubMed
23) 齋藤文誉, 田代浩徳, 松尾勇児他 : 若年発症子宮内膜癌の病態におけるプロラクチンの臨床的意義. 日婦腫瘍会誌 29 : 697-703, 2011
 
24) Thigpen JT, Brady MF, Alvarez RD et al : Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma : a dose-response study by the Gynecologic Oncology Group. J Clin Oncol 17 : 1736-1744, 1999
PubMed
25) Tashiro H, Katabuchi H : The relationship between estrogen and genes in the molecular pathogenesis of endometrial carcinoma. Curr Obstet Gynecol Rep 3 : 9-17, 2014
 
26) Cancer Genome Atlas Research Network, Kandoth C, Schultz N et al : Integrated genomic characterization of endometrial carcinoma. Nature 497 : 67-73, 2013
 
27) 日本産科婦人科学会婦人科腫瘍委員会 : 第54回治療年報. 日産婦誌 66 : 1039-1101, 2014
 
P.208 掲載の参考文献
1) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会他 (編) : 子宮体癌取扱い規約, 第3版, 金原出版, 2012
 
2) 日本婦人科腫瘍学会 (編) : 子宮体がん治療ガイドライン 2013年版, 金原出版, 2013
 
3) 櫻木範明, 嘉村敏治, 齋藤 豪他 : 子宮頸癌, 子宮体癌, 子宮体部肉腫, 外陰癌の新しいFIGO進行期分類の解説. 日産婦誌 62 : 1084-1100, 2010
 
4) 日本産科婦人科学会 (編) : 産婦人科研修の必修知識 2013, 日本産科婦人科学会, 2013
 
5) Laparoscopic Uterine Power Morcellation in Hysterectomy and Myomectomy. FDA Safety Communication, April 17, 2014
 
6) 日本産科婦人科学会, 日本病理学会 (編) : 絨毛性疾患取扱い規約, 第3版, 金原出版, 2011
 
7) 山本英子, 藤原多子, 吉川史隆 : 胞状奇胎の取扱い. 臨婦産 66 : 624-629, 2012
 
8) 井箟一彦, 谷崎優子, 馬淵泰士他 : 侵入奇胎と絨毛癌の取扱い. 臨婦産 66 : 635-640, 2012
 
9) 田代浩徳, 福永眞治, 片渕秀隆 : PSTTとETTの取扱い. 臨婦産 66 : 641-646, 2012
 
10) 磯崎太一, 竹下俊行 : 存続絨毛症の取扱い. 臨婦産 66 : 647-653, 2012
 
P.215 掲載の参考文献
1) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会他 (編) : 子宮体癌取扱い規約, 第3版, 金原出版, 2012
 
2) Kurman RJ, Kaminski PF, Norris HJ : The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer 56 : 403-412, 1985
PubMed
3) Jobo T, Tateoka K, Kuramoto H et al : Study on the longterm follow-up of endometrial hyperplasia. Int J Clin Oncol 1 : 163-169, 1996
 
4) Walker JL, Zuna RE : Endometrial hyperplasia, estrogen therapy, and the prevention of endometrial cancer. in Disaia PJ, Creasman WT (eds) : "Clinical Gynecologic Oncology", 7th ed, Mosby Elsevier, Philadephia, 2007, pp125-146
 
5) Varma R, Soneja H, Bhatia K et al : The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia-a long-term follow-up study. Eur J Obstet Gynecol Reprod Biol 139 : 169-175, 2008
PubMed
6) 日本婦人科腫瘍学会 (編) : 子宮体がん治療ガイドライン 2013年版, 金原出版, 東京, 2013
 
7) Kim MK, Yoon BS, Park H et al : Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women. Int J Gynecol Cancer 21 : 673-677, 2011
PubMed
8) Gallos ID, Yap J, Rajkhowa M et al : Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia : systematic review and metaanalysis. Am J Obstet Gnecol 207 : 266, 2012
 
9) Kinkel K, Kaji Y, Yu KK et al : Radiologic staging in patients with endometrial cancer : a meta-analysis. Radiology 212 : 711-718, 1999
PubMed
10) Nakao Y, Yokoyama M, Iwasaka T et al : MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion. Gynecol Oncol 102 : 343-347, 2006
PubMed
11) Gitsch G, Hanzal E, Jensen D et al : Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol 85 : 504-508, 1995
PubMed
12) Evans-Metcalf ER, Brooks SE, Reale FR et al : Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 91 : 349-354, 1998
PubMed
13) Kaku T, Yoshikawa H, Tsuda H et al : Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women : central pathologic review and treatment outcome. Cancer Lett 167 : 39-48, 2001
PubMed
14) Trimble CL, Kauderer JK, Zaino R et al : Concurrent endometrial carcinoma in women with biopsy diagnosis of atypical endometrial hyperplasia. Cancer 106 : 812-819, 2006
 
15) Frumovitz M, Singh DK, Meyer L et al : Predictors of final pathology in patients with endometrial cancer Gynecol Oncol 95 : 463-468, 2004
PubMed
16) Utsunomiya H, Suzuki T, Ito K et al : The correlation between the response to progestogen treatment and the expression of progesterone receptor B and 17beta-hydroxysteroid dehydrogenase type 2 in human endometrial carcinoma. Clin Endocrinol (Oxf) 58 : 696-703, 2003
PubMed
17) Ushijima K, Yahata H, Yoshikawa H et al : Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol 25 : 2798-2803, 2007
PubMed
18) Chiva L, Lapuente F, Gonzalez-Cortijo L et al : Sparing fertility in young patients with endometrial cancer. Gynecol Oncol 111 : S101-S104, 2008
PubMed
19) Wheeler DT, Bristow RE, Kurman RJ : Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Am J Surg Pathol 31 : 988-998, 2007
PubMed
20) Mentrikoski MJ, Shah AA, Hankley KZ et al : Assessing endometrial hyperplasia and carcinoma treated with progestin therapy. Am J Clin Pathol 138 : 524-534, 2012
 
21) Deligdisch L : Hormonal pathology of the endometrium. Mod Pathol 13 : 285-294, 2000
PubMed
22) Jadoul P, Donnetz J : Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma. Fertil Steril 80 : 1315-1324, 2003
PubMed
23) Elizur SE, Beiner ME, Korach J et al : Outcome of in vitro fertilization treatment in infertile women conservatively treated for endometrial adenocarcinoma. Fertil Steril 88 : 1562-1567, 2007
PubMed
24) Park JY, Lee SH, Seong SJ et al : Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin. Gynecol Oncol 129 : 7-11, 2013
PubMed
P.221 掲載の参考文献
1) Masuda K, Banno K, Yanokura M et al : Carcinoma of the lower uterine segment (LUS) : clinicopathological characteristics and association with Lynch syndrome. Curr Genomics 12 : 25-29, 2011
PubMed
2) Hachisuga T, Matsuo N, Iwasaka T et al : Human papilloma virus and P53 overexpression in carcinomas of the uterine cervix, lower uterine segment and endometrium. Pathology 28 : 28-31, 1996
PubMed
3) Zannoni GF, Vellone VG, Arena V et al : Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical-pathological and immunohistochemical study. Virchows Arch 457 : 27-34, 2010
PubMed
4) Ayeni TA, Bakkum-Gamez JN, Mariani A et al : Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas. Gynecol Oncol 129 : 478-485, 2013
PubMed
5) Zaino R, Carinelli SG, Ellenson LH et al : Tumours of the uterine corpus. in Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : "WHO Classification of Tumours of Female Reproductive Organs", 4th ed, IARC Press, Lyon, 2014, pp121-135
 
6) McConechy MK, Ding J, Senz J et al : Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles. Mod Pathol 27 : 128-134, 2014
PubMed

書評

最近チェックした商品履歴

Loading...